On the safety of E-cigarettes: "I can resist anything except temptation"

ATLA Alternatives to Laboratory Animals

Volumn 43, Issue 6, 2015, Pages 417-425

  Combes, Robert D ^a   Balls, Michael ^b  

^a Russell and Burch House ^*  (United Kingdom)

^b RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONIC CIGARETTE; ENVIRONMENTAL EXPOSURE; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; NOTE; PRIORITY JOURNAL; PRODUCT SAFETY; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SMOKING; SMOKING HABIT; UNITED KINGDOM; ADVERSE EFFECTS; ANIMAL; LEGISLATION AND JURISPRUDENCE; MARKETING; TOBACCO;

ANIMALS; HUMANS; MARKETING; RISK ASSESSMENT; TOBACCO PRODUCTS;

EID: 84956913154     PISSN: 02611929     EISSN: 26323559     Source Type: Journal    
DOI: 10.1177/026119291504300610     Document Type: Note

References (45)

1. Wilde, O. (1892). A quotation from Lady Windermere's Fan, a play first performed in 1892 and first published in written form in 1893.
2. Combes, R.D. & Balls, M. (2015). A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products. ATLA 43, 251-290.
3. Anon. (2015). E-cigarettes: A new foundation for evidence-based policy and practice, 6pp. Available at: https://www.gov.uk/government/uploads/system/ uploads/attachment-data/file/454517/Ecigarettes-a- firm-foundation-for-evidence-based-policy-and- practice.pdf (Accessed 19.08.15).
4. Gureckis, T.M. & Love, B.C. (2009). Short term gains, long term pains: How cues about state aid learning in dynamic environments. Cognition 113, 293-313.
5. Bates, C. & Stimson, G. (2013). Costs and Burdens of Medicines Regulation for e-Cigarettes. A Report: 20 September 2013, 26pp. Available at: http://www. e-cigarette-summit.com/files/2014/07/Impacts-ofmedicines-regulation-V4-22-09-2013.pdf (Accessed 06.11.15).
6. McNeill, A., Brose, L.S., Calder, R., Hitchman, S.C., Hajek, P. & McRobbie, H. (2015). E-cigarettes: An evidence update. A report commissioned by Public Health England, 113pp. London, UK: Public Health England. Available at: https://www.gov.uk/government/ uploads/system/uploads/attachment-data/file/457102/ Ecigarettes-an-evidence-update-A-report- commissioned-by-Public-Health-England-FINL.pdf (Accessed 07.11.15).
7. Britton, J. & Bogdanovica, I. (2014). Electronic Cigarettes. A report commissioned by Public Health England, 30pp. London, UK: Public Health England. Available at: https://www.gov.uk/government/uploads/ system/uploads/attachment-data/file/311887/ Ecigarettes-report.pdf (Accessed 07.11.15).
8. Hengstler, J.G., Bogdanffy, M.S., Bolt, H.M. & Oesch, F. (2002). Challenging dogma: Thresholds for genotoxic carcinogens? The case of vinyl acetate. Annual Reviews of Pharmacology 43, 485-520.
9. Cheng, T. (2014). Chemical evaluation of electronic cigarettes. Tobacco Control 23, Suppl. ii, 11-17.
10. Williams, M. (2013). Electronic cigarette liquids and vapors: Is it harmless water vapor? Webinar presentation. Available at: http://www.trdrp.org/files/ e-cigarettes/williams-slides.pdf (Accessed 07.11.15).
11. Kim, H.J. & Shin, H.S. (2013). Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography-tandem mass spectrometry. Journal of Chroma-tography A 1291, 48-55.
12. Akopyan, G. & Bonavida, B. (2006). Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. International Journal of Oncology 29, 745-752.
13. Neuberger, M. (2015). The electronic cigarette: A wolf in sheep's clothing. Wiener Klinische Wochenschrift, Central European Journal of Medicine, doi: 10.1007/ s00508-015-0753-3. Available at: http://www.forte.or. at/download.php?id=1725 (Accessed 06.11.15).
14. Cochrane, S.A., Arts, J.H.E., Ehnes, C., Hindle, S., Heli, M., Hollnagel, S.H.M., Poole, A. Suto, H. & Kimber, I. (2015). Thresholds in chemical respiratory sensitisation. Toxicology 333, 179-194.
15. Megaraj, V., Zhou, X., Xie, F., Liu, Z., Yang, W. & Ding, X. (2014). Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: In vivo studies using a CYP2A13-humanised mouse model. Carcinogenesis 35, 131-137.
16. Farsalinos, K.E., & Polosa, R. (2014). Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: A systematic review. Therapeutic Advances in Drug Safety 5, 67-86.
17. Gardiner, P. (2013). E-Cigarettes: The Vapor This Time? 18pp. Available at: www.trdrp.org/files/e-cigarettes/ e-cigarettes-the-vapor-this-time.pdf (Accessed 07.11.15).
18. Nutt, D.J., Phillips, L.D., Balfour, D., Curran, H.V., Dockrell, J.M., Foulds, J., Fagerstrom, K., Letlape, K., Milton, A., Polosa, R., Ramsey, J. & Sweanor, D. (2014). Estimating the harms of nicotine-containing products using the MCDA approach. European Addiction Research 20, 218-225.
19. Kujawski, E. (2002). Multi-criteria decision analysis: Limitations, pitfalls, and practical difficulties, 9pp. Berkeley, CA, USA: eScholarship, University of California. Available at: http://escholarship.org/uc/ item/0cp6j7sj (Accessed 07.11.15).
20. Brose, L.S., Brown, J., Hitchman, S.C. & McNeill, A. (2015). Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug & Alcohol Dependence 157, 106-111.
21. Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J. & Walker, N. (2013). Elec-tronic cigarettes for smoking cessation: A randomised controlled trial. The Lancet 382, 1629-1637.
22. McKee, M. & Capewell, S. (2015). Evidence about electronic cigarettes: A foundation built on rock or sand? BMJ 351, h4863.
23. Kirby, T. (2015). E-cigarettes declared 95% less harmful than tobacco by UK health body. The Lancet Respiratory Medicine 3, 750-751.
24. Culpan, D. (2015). E-cigarettes 'safer than tobacco' study faces Lancet criticism. Wired.co.uk, 4 September 2015. Available at: http://www.wired.co.uk/news/ archive/2015-09/04/e-cigarette-report-criticised-thelancet (Accessed 07.11.15).
25. Britton, J. (2015). E-cigarettes, Public Health England, and common sense. The Lancet 386, 1238-1239.
26. Knapton, S. (2015). E-cigarette 'safety' study was written by industry funded scientists, Lancet warns. The Telegraph, Science News, 28 August 2015. Available at: http://www.telegraph.co.uk/news/science/ science-news/11830029/E-cigarette-safety-study-waswritten-by-industry-funded-scientists-Lancet-warns. html (Accessed 07.11.15).
27. Pisinger, C. & Døssing, M. (2014). A systematic review of health effects of electronic cigarettes. Preventive Medicine 69, 248-260.
28. Rowell, T.R. & Tarran, R.A. (2015). Will chronic e-Cigarette use cause lung disease? American Journal of Physiology-Lung Cellular & Molecular Physiol-ogy, doi: 10.1152/ajplung.00272.2015. [E-pub ahead of print.]
29. Unger, J.B. (2015). E-Cigarettes: Introducing new complexities and controversies to the field of nicotine and tobacco research. Nicotine & Tobacco Research 17, 1185-1186.
30. Etter, J-F., Bullen, C., Flouris, A.D., Laugesen, M. & Eissenberg, T. (2011). Electronic nicotine delivery systems: A research agenda. Tobacco Control 20, 243-248.
31. Misra, M., Leverette, R.D., Cooper, B.T., Bennett, M.B. & Brown, S.E. (2014). Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: E-liquids, extracts and collected aerosols. International Journal of Environmental Research & Public Health 11, 11,325-11,347.
32. Neilson, L., Mankus, C., Thorne, D., Jackson, G., DeBay, J. & Meredith, C. (2015). Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. Toxicology in Vitro 29, 1952-1962.
33. Murphy, N. (2015). 5 Marijuana Vaporizers Offering a Better, Healthier High. The Cheat Sheet, 28 October 2015. Available at: http://www.cheatsheet.com/ business/5-marijuana-vaporizers-offering-a-betterhealthier-high.html/?a=viewall#ixzz3lBQ3vxHd (Accessed 06.11.15).
34. Sancilio, S., Gallorini, M., Cataldi, A. & di Giacomo, V. (2015). Cytotoxicity and apoptosis induction by e-cigarette fluids in human gingival fibroblasts. Clinical Oral Investigations, 2015 Aug 4. [E-pub ahead of print.]
35. Caponnetto, P., Campagna, D., Papale, G., Russo, C. & Polosa, R. (2012). The emerging phenomenon of electronic cigarettes. Expert Review of Respiratory Medicine 6, 63-74.
36. Vansickel, A.R., Cobb, C.O., Weaver, M.F. & Eissenberg, T.E. (2010). A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": Nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiology, Bio-markers & Prevention 19, 1945.
37. Palamidas, A., Gennimata, S.A., Kaltsakas, G., Tsikrika, S., Vakali, S., Gratziou, C. & Koulouris, N. (2014). Acute effect of an e-cigarette with and without nicotine on lung function. Tobacco Induced Diseases 12, Suppl. 1, A34.
38. Phillips, C.V. (2012). The biomarkers lie. Tobacco Harm Reduction Blog at WordPress.com. Available at: http://antithrlies.com/2012/09/07/the-biomarkers-lie/ (Accessed 06.11.15).
39. Flacco, M.E., Fiore, M., La Vecchia, C., Marzuillo, C., Gualano, M.R., Liguori, G., Cicolini, G., Capasso, L., Boccia, S., Siliquini, R., Ricciardi, W., Villari, P. & Manzoli, L. (2015). Electronic cigarettes: Efficacy and safety at 12 months: Cohort study. European Journal of Public Health 25, Suppl. 3, 254.
40. Brandon, T.H., Goniewicz, M.L., Hanna, N.H., Hatsukami, D.K., Herbst, R.S., Hobin, J.A., Ostroff, J.S., Shields, P.G., Toll, B.A., Tyne, C.A., Viswanath, K. & Warren, G.W. (2015). Electronic nicotine delivery systems: A policy statement from the American Association for Cancer Research and the American Society of Oncology. Journal of Clinical Oncology 33, 952-963.
41. Anon. (2015). Vaping needs stronger regulation, say doctors leaders. London, UK: British Medical Assoc-iation. Available at: http://bma.org.uk/news-viewsanalysis/ news/2015/august/vaping-needs-strongerregulation-say-doctors-leaders (Accessed 06.11.15).
42. Combes, R., Balls, M., Illing, P., Bhogal, N., Dale, J., Duvé, G., Feron, V., Grindon, C., Gülden, M., Loizou, G., Priston, R. & Westmoreland, C. (2006). Possib-ilities for a new approach to chemicals risk assessment. The Report of a FRAME Workshop. ATLA 34, 621-649.
43. Combes, R.D. (1997). Defining a 'threshold of regulation' the ultimate alternative for safety assessment? ATLA 25, 187-191.
44. Sepanov, I., Carmella, S.G., Han, S., Pinto, A., Strasser, A.A., Lerman, C. & Hecht, S.S. (2009). Evidence for endogenous formation of N-nitrosonornicotine in some long-term nicotine patch users. Nicotine & Tobacco Research 11, 99-105.
45. Hahn, J., Monakhova, Y.B., Hengen, J., Kohl-Himmelseher, M., Schu?ssler, J., Hahn, H., Kuballa, T. & Lachenmeier, D.W. (2014). Electronic cigarettes: Overview of chemical composition and exposure estimation. Tobacco Induced Diseases 12, 23.